Safety and efficacy of rapid dose administration of quetiapine in bipolar mania
in this open-label pilot study, 20 adult patients hospitalized for acute bipolar mania received oral quetiapine as a single evening dose of 200 mg on day 1, increased by 200 mg/day on days 2, 3, and 4 until 800 mg/day taken in 2 divided doses on day 4. From day 5 onward, patients received a flexible...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Published: |
2006
|
| Subjects: |